Catalyst Wire Dossier Catalyst Wire Dossier

DBI-002 Gel

DBI-002 Gel · DermBiont, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DBI-002 Gel, covering 2023-02-14 to 2023-02-14. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis [Phase 2]

See pricing